We are currently seeking Editorial Board Members for “Glucolipid Metabolic Disorders”
We are seeking experienced researchers and scientists to join us as Editorial Board Members for the journal, \"Glucolipid Metabolic Disorders”
About the Role:
Actively contribute to the development and growth of the journal by providing valuable scholarly input, including the selection of topics, reviewers, and authors.
Contribute/solicit Special Thematic Issues on a trending topic (one thematic issue every year).
Review articles submitted to the journal (at least thrice a year) in your area of expertise.
Requirements:
Scientist or researcher (PhD) with experience in Glucolipid Metabolic Disorders in clinical, medical, and pharmaceutical research, and related subject areas.
At least 5 years of experience in peer-reviewing, editing, and writing research papers.
Verifiable record of publications in peer-reviewed journals indexed in WOS Core Collection and/or Scopus.
Ability to communicate clearly and timely with stakeholders in the English language.
Benefits:
Save APCs on publishing your research
As an Editorial Board Member, you will be entitled to publish your papers and thematic issues, free of cost.
Keep tabs on the latest research
Editorial Board Members will be able to access and review new research/review papers as they are submitted to the journal, allowing them to keep abreast of the latest trends in Glucolipid Metabolic Disorders in clinical, medical, and pharmaceutical research, and related subject areas.
Network with a community of scholars
You will be able to connect with professionals, scholars, and experts on our editorial board, opening new opportunities to collaborate on novel research projects and broaden your perspective in the field.
About the Journal:
Glucolipid Metabolic Disorders is an international, peer-reviewed, multi-disciplinary journal for physicians, clinicians, and scientists with an interest in glucose and lipid metabolic disorders in pathological processes, as well as the therapeutics targeting these disorders to treat human diseases.
Glucolipid Metabolic Disorders publishes original research articles, guidelines, reviews, and commentaries on a broad range of topics. The journal is particularly interested in manuscripts that address important advances in glucolipid metabolomics and the clinical application of targeting glucose and lipid metabolism. Areas of interest cover, but are not limited to:
• Clinical applications of targeting glucose and lipid metabolism to improve patient care and outcomes
• Clinical trials illustrating the use of targeting glucose and lipid metabolism
• Conceptual characterization of glucolipid metabolic disorders
• Mechanisms of glucolipid metabolic disorders in diseases
• Metabolomics of glucose and lipids
• Methodologies & preclinical and clinical applications of glucolipid metabolomics
• Novel techniques & approaches for the advancement of glucolipid metabolomics
• Translational research in glucolipid metabolomics
Glucolipid Metabolic Disorders is an international, peer-reviewed journal on all aspects of glucolipid metabolomics, published continuously (print & online) by Bentham Science Publishers.